GeneNews Ltd. operates as a molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management based on disease-specific biomarkers. The company's active business is carried out by its wholly-owned subsidiary, GeneNews Corp. It has developed a platform technology, the Sentinel Principle, which has the power to detect and stage virtually any disease or medical condition from a simple blood sample. The company is currently applying the Sentinel Principle in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.